| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05ff905fdc49089f5f25746eaeb40190 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12R2001-04 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P1-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-03 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07G11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P1-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74 |
| filingDate |
1984-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1985-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8820c2ea7a86268edeb7bc2859999238
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef821c2829e8ab257008007ad18af45f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb8594ff59d986e62ea2c0449a596ffd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7200318d418de176f6fc788e2307cb1a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3189abc51ad28e0bb3b03c024669fe18 |
| publicationDate |
1985-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-4554162-A |
| titleOfInvention |
CL-1724 Antibiotic compounds, their production and use |
| abstract |
A strain of actinomycete, NRRL 15758, is capable of producing the CL-1724 complex of compounds under conditions of aerobic fermentation in the presence of assimilable sources of carbon and nitrogen. The compound CL-1724B-2 exhibiting antimicrobial and antitumor activity, is claimed together with pharmaceutical compositions and methods of treating microbial infections and tumors in mammals employing these pharmaceutical compositions. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5037651-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4996305-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4910017-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4939244-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014012165-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5770710-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009105461-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004023910-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007160577-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006002942-A1 |
| priorityDate |
1984-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |